Foundayo (Orforglipron): The UK Guide to the New Weight-Loss Tablet

Weight-loss medicines have improved a lot in a short time, but they have all asked something of the patient — a weekly injection, a fridge, or a strict morning fasting routine.

Foundayo is different in one specific and genuinely practical way: there are no food, water or timing restrictions. You take it once a day, whenever suits you. For shift workers, parents doing the school run, people who travel, or anyone whose mornings simply are not calm enough for a 30-minute fasting window, that removes a real barrier.

This guide covers what Foundayo is, how it works, who it is licensed for, what the trial evidence shows, the side effects to plan for, and how it compares with the other options available in the UK.

What is Foundayo?

Foundayo is the brand name for orforglipron, a prescription-only, once-daily tablet developed by Eli Lilly for weight management and for type 2 diabetes. It belongs to the GLP-1 receptor agonist family — the same broad group as Wegovy and Mounjaro — but it is built differently.

Most GLP-1 medicines are peptides: large, fragile molecules that the digestive system breaks down, which is why they are usually injected, or need special formulation and a fasting routine when given as a tablet. Orforglipron is a small-molecule, non-peptide GLP-1 receptor agonist. That chemistry is what allows it to be absorbed reliably without the food and water restrictions other oral GLP-1 medicines require.

How does Foundayo work?

Foundayo works by activating GLP-1 receptors, mimicking a natural hormone your gut releases after eating that signals fullness to the brain. The result for most people is reduced appetite, feeling satisfied with smaller portions, and less preoccupation with food.

It also affects how the body handles blood sugar, which is why it holds a separate licence for type 2 diabetes. GLP-1 receptor agonists increase insulin release when blood glucose is high and reduce the release of glucagon, a hormone that raises blood sugar.

In everyday terms, people taking a GLP-1 medicine commonly report:

• Feeling full earlier in a meal, and staying full longer
• Fewer cravings and less snacking between meals
• A quieter relationship with food overall — the constant mental “what’s next” tends to fade

Is Foundayo available in the UK?

Yes. Foundayo was authorised by the MHRA on 10 August 2026 and is available in the UK on private prescription through registered pharmacies following a clinical assessment. The UK was the first country in Europe to authorise it.

It is not currently available on the NHS. NICE is evaluating orforglipron for weight management, with guidance expected in late 2026. Until any NHS funding decision is made, access is private.

Foundayo prices

Foundayo is supplied privately, and the price depends on the strength you are prescribed. Our current pricing is:

A 30-tablet pack covers one month of once-daily treatment.

Who may be suitable for Foundayo?

Foundayo is licensed for adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related health condition, alongside a reduced-calorie diet and increased physical activity. It is also licensed to improve glycaemic control in adults with insufficiently controlled type 2 diabetes.

Weight-related conditions a prescriber may take into account include:

• Type 2 diabetes or prediabetes
• High blood pressure
• Raised cholesterol or triglycerides
• Obstructive sleep apnoea
• Cardiovascular disease
• Osteoarthritis of the knees, hips or ankles
• Non-alcoholic fatty liver disease

Foundayo may particularly suit people who:

• Would rather not inject, or have a needle phobia
• Struggle with the fasting routine required by other oral GLP-1 tablets
• Work shifts or irregular hours, where a fixed morning routine is unrealistic
• Travel frequently and would prefer not to manage refrigerated medicines
• Have both excess weight and type 2 diabetes to address

Who should not take Foundayo?

Foundayo is not suitable for everyone. It should not be taken if you:

• Are pregnant, trying to conceive, or breastfeeding
• Are under 18
• Have a personal or family history of medullary thyroid carcinoma, or multiple endocrine neoplasia syndrome type 2 (MEN 2)
• Have had an allergic reaction to orforglipron or any of the tablet’s ingredients
• Have severe liver impairment
• Are already taking another GLP-1 medicine
• Have a current or previous eating disorder

Additional caution, monitoring or an alternative treatment may be needed if you have:

• A history of pancreatitis or gallstones
• Type 1 diabetes, or type 2 diabetes treated with insulin or a sulfonylurea
• Diabetic retinopathy
• Kidney disease, or a condition that makes dehydration more likely
• Gastroparesis or other significant gastrointestinal disease
• A history of depression or suicidal thoughts

This list is a summary. The patient information leaflet supplied with your medicine contains the full details, and your prescriber will assess your individual situation.

How is Foundayo taken?

Take one Foundayo tablet once a day, at any time of day, with or without food. There is no fasting requirement and no restriction on what you drink. Swallow the tablet whole.

1. Pick a time that you will actually remember. With breakfast, at lunch, before bed — it does not matter clinically, so choose whatever anchors best in your routine.
2. Swallow the tablet whole. Do not crush, split or chew it.
3. Eat and drink normally. No waiting period, no plain-water rule.
4. Stay on your starting strength for at least a month before any increase, so your body can adjust.
5. Check in before each dose increase so your prescriber can review how you are getting on.

Foundayo dose schedule

Foundayo is titrated — the dose is stepped up gradually to reduce side effects.

What can I expect, and how quickly does Foundayo work?

Appetite changes often appear within the first few weeks, but weight change is assessed over months. The starting dose is low by design, and the first month is about tolerance rather than results.

What does the research show?

The main weight-management evidence comes from the ATTAIN-1 trial, published in the New England Journal of Medicine in 2025. It included 3,127 adults with obesity and without diabetes across nine countries, over 72 weeks, alongside diet and exercise.

• Average weight change was −7.5%, −8.4% and −11.2% across the three doses studied, compared with −2.1% on placebo.
• At the highest dose studied, 55% of participants lost at least 10% of their body weight (vs 13% on placebo), 36% lost at least 15% (vs 6%), and 19% lost at least 20% (vs 3%).
• Gastrointestinal side effects were the most common, and were mostly mild to moderate.
• Stopping treatment because of side effects occurred in around 5–10% of participants taking orforglipron, compared with 3% on placebo.

Foundayo and type 2 diabetes

Foundayo also holds a UK licence to improve glycaemic control in adults with insufficiently controlled type 2 diabetes, alongside diet and exercise. In practice this means it may be considered where blood sugar targets are not being met with existing treatment.

If you have type 2 diabetes, treatment decisions are more involved: your other diabetes medicines may need adjusting, particularly insulin or sulfonylureas, and your blood glucose monitoring may need to change. This is normally coordinated with your diabetes team or GP rather than managed in isolation.

Side effects of Foundayo

The most commonly reported side effects are nausea, constipation, diarrhoea, vomiting, indigestion and abdominal pain. They are typically most noticeable early on and after each dose increase, and often settle as the body adjusts.

Common side effects

• Nausea
• Constipation
• Diarrhoea
• Vomiting
• Dyspepsia (indigestion)
• Abdominal pain
• Burping, bloating or wind
• Headache and tiredness
• Reduced appetite (expected, and part of how it works)

How to make the first weeks easier

• Smaller meals, eaten slowly. The most reliable single change.
• Ease off very fatty, fried or rich food while you are adjusting.
• Drink water steadily through the day.
• Fibre and movement to keep constipation at bay; ask your pharmacist if it persists.
• Stop eating at “satisfied”, not “finished”.
• Do not rush the next dose increase. Staying put for an extra month is a legitimate option — tell us rather than pushing through.

Less common but important

Seek medical advice promptly if you notice:

• Severe, persistent abdominal pain, particularly radiating to the back with vomiting — this may indicate pancreatitis and needs urgent assessment
• Upper right abdominal pain, yellowing of the skin or eyes, or pale stools — possible gallbladder problems
• Signs of dehydration or reduced urine output
• Symptoms of low blood sugar — more likely if you also take insulin or a sulfonylurea
• New or worsening vision changes, especially if you have diabetes
• A lump or swelling in the neck, persistent hoarseness or difficulty swallowing
• Swelling of the face, lips or throat, or difficulty breathing — seek emergency help
• Low mood or thoughts of self-harm

Interactions and precautions

Because Foundayo slows stomach emptying, it can affect how quickly other oral medicines are absorbed. Give your prescriber a complete list of what you take, including supplements and anything bought over the counter.

• Insulin and sulfonylureas — increased risk of low blood sugar; doses often need reviewing.
• Oral contraceptives — if you experience significant vomiting, contraceptive absorption may be affected; use additional precautions and seek advice.
• Medicines with a narrow therapeutic range, such as warfarin — monitoring may be advised.
• Other GLP-1 medicines — should not be taken alongside Foundayo.
• Alcohol — can worsen nausea and adds calories; moderation is sensible.

How does Foundayo compare with other weight-loss treatments?

The main practical differences are the format, the routine each one demands, and whether it also carries a type 2 diabetes licence.

Can I switch to Foundayo from another weight-loss medicine?

Switching is often possible, but it is a clinical decision rather than a simple swap. Your prescriber will consider which medicine you are on, the dose you have reached, how well you tolerated it, and why you want to change. In most cases you will not simply continue at an equivalent strength — a fresh titration is usually needed, because doses are not interchangeable between different active ingredients.

Never overlap two GLP-1 medicines, and never start a new one before agreeing the plan with your prescriber.

What if I miss a dose of Foundayo?

If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed one and carry on as normal. Do not take two tablets on the same day.

Because there are no timing restrictions, catching up later the same day is usually straightforward — one of the practical advantages of this medicine. If you have missed several doses in a row, or stopped for a couple of weeks or more, contact your prescriber before restarting rather than resuming at your previous strength.

What happens during an online consultation?

An online consultation for Foundayo is a clinical assessment carried out by a UK-registered prescriber. The purpose is to establish whether the medicine is safe and appropriate for you — and sometimes the answer will be that it is not.

1. Complete the health questionnaire — height, weight, medical history, medicines, allergies and previous weight-loss treatment.
2. Provide the required evidence of your weight, such as a photograph or recent recorded measurement.
3. Prescriber review. They check eligibility and safety, and may ask follow-up questions or seek information from your GP.
4. Agree the plan. Starting dose, what to expect, how to manage side effects and when to check in.
5. Pharmacist check and dispensing. Your medicine is clinically checked and delivered discreetly.
6. Ongoing reviews before each dose increase and at agreed intervals.

We would always recommend telling your GP that you have started a weight-management medicine, so your records stay complete — particularly important if you have type 2 diabetes or take other regular medication.

How is treatment monitored?

• Weight and BMI reviewed at agreed intervals
• Side-effect review before each dose increase
• Blood pressure, and blood glucose or HbA1c where relevant
• Blood tests where clinically indicated — for example kidney, liver or thyroid function and lipids
• A frank review of whether to continue if the response is limited

If you have type 2 diabetes, monitoring will be closer, especially in the early weeks while other diabetes medicines are adjusted.

Getting the most from treatment

Foundayo is licensed for use alongside a reduced-calorie diet and increased physical activity. The medicine reduces the pull of hunger; what you build during that period determines how durable the result is.

• Prioritise protein at each meal to help protect muscle while losing weight.
• Include resistance exercise twice a week — this matters more than most people realise.
• Eat by plan, not by appetite. When hunger drops sharply, under-eating and nutrient gaps become a genuine risk.
• Keep hydrated, particularly if your food intake has fallen significantly.
• Think about the exit early. Weight regain after stopping GLP-1 treatment is common; plan your maintenance approach with your prescriber before you need it.

Frequently asked questions

When should I speak to a healthcare professional?

Contact your prescriber, GP or pharmacist if:

• Side effects are severe or are not improving after a few weeks
• You have severe or persistent stomach pain, or repeated vomiting
• You cannot keep fluids down or show signs of dehydration
• You have type 2 diabetes and your blood glucose readings change significantly
• You become pregnant or are planning to
• You have an operation, endoscopy or procedure planned
• You are not getting a worthwhile response despite taking the medicine as prescribed
• Your mood changes, or you have thoughts of harming yourself

For severe abdominal pain, breathing difficulty or swelling of the face or throat, seek urgent help — call 999 or go to A&E. For non-urgent advice, NHS 111 is available 24 hours a day.

References and further reading

Medical disclaimer: This article is for general information and does not replace personalised medical advice. Foundayo is a prescription-only medicine and is not suitable for everyone. Always read the patient information leaflet supplied with your medicine and discuss your individual circumstances with a qualified healthcare professional.